APRE vs JNJ: Which Stock is Better?
Side-by-side comparison of Aprea Therapeutics Inc and Johnson & Johnson in 2026
APRE
Aprea Therapeutics Inc
—
JNJ
Johnson & Johnson
$263.04
Key Metrics Comparison
| Metric | APRE | JNJ | Winner |
|---|---|---|---|
| Market Cap | $10.40M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze APRE
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APRE or JNJ a better investment?
Comparing APRE and JNJ: Aprea Therapeutics Inc has a market cap of $10.40M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APRE and JNJ?
APRE (Aprea Therapeutics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APRE or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APRE or JNJ?
Both APRE and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: APRE or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: APRE or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $10.40M for APRE.
Should I buy APRE or JNJ in 2026?
Both APRE and JNJ have investment merit. APRE trades at $N/A while JNJ trades at $263.04. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APRE and JNJ stock?
Key differences: Market Cap ($10.40M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy APRE or JNJ in 2026?
The choice between APRE and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between APRE and JNJ?
APRE (Aprea Therapeutics Inc) has a market cap of $10.40M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.